Loading...
XNYSLCTX
Market cap98mUSD
Jan 10, Last price  
0.58USD
1D
8.98%
1Q
-32.20%
Jan 2017
-83.93%
Name

Lineage Cell Therapeutics Inc

Chart & Performance

D1W1MN
XNYS:LCTX chart
P/E
—
P/S
11.03
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
6.35%
Rev. gr., 5y
44.58%
Revenues
9m
-39.16%
688,377903,2001,162,0151,046,1211,503,7921,925,1683,680,3004,354,7621,692,8692,861,0071,946,3722,534,0002,252,0001,792,0001,416,0001,478,000773,0003,896,00014,703,0008,945,000
Net income
-21m
L-18.47%
-3,085,324-2,074,251-1,864,621-1,438,226-3,780,895-5,143,909-11,184,618-16,515,500-21,425,703-43,882,835-36,411,660-46,991,00033,572,000-19,976,000-45,990,000-11,827,000-20,685,000-38,564,000-26,353,000-21,486,000
CFO
-29m
L
-1,536,696-1,414,148-1,262,219-1,239,980-1,604,245-4,259,938-7,732,884-13,593,916-19,679,518-29,508,613-38,854,200-44,544,000-42,326,000-30,517,000-30,882,000-31,947,000-19,753,000-23,561,0001,059,000-28,566,000
Earnings
Mar 05, 2025

Profile

Boatim Inc. operates online marketplace and special interest social network for the boating industry and boat users. The company operates boatim.com, an online boat trading marketplace platform. The company was formerly known as Emerald Data Inc. and changed its name to Boatim Inc. in February 2019. Boatim Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
URL
https://lineagecell.com/
IPO date
Mar 05, 1992
Employees
70
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,945
-39.16%
14,703
277.39%
Cost of revenue
33,678
37,223
Unusual Expense (Income)
NOPBT
(24,733)
(22,520)
NOPBT Margin
Operating Taxes
(1,803)
541
Tax Rate
NOPAT
(22,930)
(23,061)
Net income
(21,486)
-18.47%
(26,353)
-31.66%
Dividends
Dividend yield
Proceeds from repurchase of equity
6,588
1,664
BB yield
-3.50%
-0.84%
Debt
Debt current
1,764
952
Long-term debt
5,022
6,840
Deferred revenue
18,693
27,725
Other long-term liabilities
2
Net debt
(28,706)
(50,664)
Cash flow
Cash from operating activities
(28,566)
1,059
CAPEX
(674)
(413)
Cash from investing activities
46,449
(46,159)
Cash from financing activities
6,423
1,632
FCF
(22,024)
(16,956)
Balance
Cash
35,492
57,875
Long term investments
581
Excess cash
35,045
57,721
Stockholders' equity
62,023
71,936
Invested Capital
49,505
45,838
ROIC
ROCE
EV
Common stock shares outstanding
172,663
169,792
Price
1.09
-6.84%
1.17
-52.24%
Market cap
188,203
-5.26%
198,657
-50.71%
EV
158,101
146,590
EBITDA
(24,041)
(21,793)
EV/EBITDA
Interest
5,181
Interest/NOPBT